ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) shares saw unusually-high trading volume on Friday . Approximately 4,931,217 shares were traded during trading, an increase of 211% from the previous session’s volume of 1,585,373 shares.The stock last traded at $8.18 and had previously closed at $7.71.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on ASPI shares. HC Wainwright dropped their price target on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. Canaccord Genuity Group assumed coverage on shares of ASP Isotopes in a research note on Friday, October 4th. They issued a “buy” rating and a $4.50 price target for the company. Finally, Canaccord Genuity Group reissued a “buy” rating and set a $4.50 price objective on shares of ASP Isotopes in a research report on Friday, October 18th.
Check Out Our Latest Analysis on ASPI
ASP Isotopes Trading Up 8.2 %
ASP Isotopes (NASDAQ:ASPI – Get Free Report) last issued its earnings results on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. ASP Isotopes had a negative return on equity of 177.29% and a negative net margin of 807.39%. The firm had revenue of $1.02 million during the quarter. Analysts anticipate that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.
Hedge Funds Weigh In On ASP Isotopes
A number of large investors have recently modified their holdings of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new stake in ASP Isotopes in the 3rd quarter valued at $6,249,000. Telemark Asset Management LLC purchased a new stake in ASP Isotopes in the 3rd quarter valued at $4,726,000. Geode Capital Management LLC raised its position in ASP Isotopes by 42.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after buying an additional 334,836 shares during the last quarter. Vanguard Group Inc. raised its position in ASP Isotopes by 479.1% in the 1st quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after buying an additional 844,705 shares during the last quarter. Finally, Philadelphia Financial Management of San Francisco LLC raised its position in ASP Isotopes by 158.3% in the 3rd quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock valued at $2,757,000 after buying an additional 607,893 shares during the last quarter. 16.80% of the stock is currently owned by institutional investors.
ASP Isotopes Company Profile
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Further Reading
- Five stocks we like better than ASP Isotopes
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Tesla Investors Continue to Profit From the Trump Trade
- Comparing and Trading High PE Ratio Stocks
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- How Investors Can Find the Best Cheap Dividend Stocks
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.